Virpax Pharmaceuticals Inc. (VRPX) reported a transaction involving Shah Vinay, the company's Chief Financial Officer. The transaction took place on January 29, 2024. However, the announcement did not disclose the number of shares transacted, the nature of the shares, the transaction price, or the total value of the shares. Additionally, the number of shares held by Shah Vinay after the transaction was not provided. Investors are advised to note the involvement of a key executive in the transaction, which could be indicative of the company's financial maneuvers.

Virpax Pharmaceuticals Inc. (VRPX) reported a transaction involving Shah Vinay, the company's Chief Financial Officer. The transaction took place on January 29, 2024. However, the announcement did not disclose the number of shares transacted, the nature of the shares, the transaction price, or the total value of the shares. Additionally, the number of shares held by Shah Vinay after the transaction was not provided. Investors are advised to note the involvement of a key executive in the transaction, which could be indicative of the company's financial maneuvers.